Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study. Dagogo-Jack I, Cooper AJ, Johnson BE, Gainor JF, et al. Lung Cancer 2024;199:108003.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dagogo-Jack I, Cooper AJ, Johnson BE, Gainor JF, et al. Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study. Lung Cancer 2024;199:108003.
PMID: 39615410